id: combined_alcohol_cardiometabolic_risk_to_aud_hospitalization
name: Combined Alcohol and Cardiometabolic Risk (MetALD) â†’ Alcohol Use Disorder Hospitalization
from_node:
  node_id: combined_alcohol_cardiometabolic_risk
  node_name: Combined Alcohol and Cardiometabolic Risk (MetALD)
to_node:
  node_id: aud_hospitalization
  node_name: Alcohol Use Disorder Hospitalization
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Patients with both increased alcohol intake and metabolic dysfunction (MetALD)
  experience dual pathogenic processes affecting liver and systemic health'
- 'Step 2: Metabolic dysfunction may exacerbate alcohol-related liver injury and systemic
  complications'
- 'Step 3: Continued hazardous alcohol use despite metabolic comorbidities leads to
  acute decompensation requiring hospitalization'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Catherine Mezzacappa et al. 2025. "Validation and Epidemiologic
    Definition of the Novel Steatotic Liver Disease Nomenclature in a National United
    States Cohort With Cirrhosis.." *Clinical gastroenterology and hepatology : the
    official clinical practice journal of the American Gastroenterological Association*.
    https://doi.org/10.1016/j.cgh.2024.10.035'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.377497'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/combined_alcohol_cardiometabolic_risk_to_aud_hospitalization.yaml
_category: biological
